Should Investors Be Buying Zynerba Pharmaceuticals (ZYNE) Stock ... | zyne stock pricezyne stock price
Advertisement
["1025.29"]
What's in Store for Zynerba Pharmaceuticals Inc (ZYNE) Following ... | zyne stock priceZynerba Pharmaceuticals, Inc. shares had a trading aggregate of 27K on Thursday. Aggregate was bottomward 91.68% beneath the stocks boilerplate circadian volume.
Short traders are activity a little added bullish on shares of Zynerba Pharmaceuticals, Inc. afresh attractive at the downtick in abbreviate interest. The banal had a abatement in abbreviate absorption of -9.42% as of September 15, 2017 from the aftermost advertisement period. Abbreviate shares fell from 2,265,898 to 2,052,453 over that timeframe. Days to awning added from 4.0 to 6.0 and the abbreviate absorption allotment is 0.16% as of September 15.
The afterward firms accept afresh afflicted their position in ZYNE. Creative Planning grew its affairs by affairs 700 shares an access of 409.4% in the quarter. Creative Planning owns 871 shares admired at $15,000. The absolute amount of its backing added 400.0%. Ubs Group Ag bald its position by affairs 2,853 shares a abatement of 73.2% as of 06/30/2017. Ubs Group Ag now holds 1,044 shares with a amount of $18,000. The amount of the position all-embracing is bottomward by 76.9%.
["679"]
Zynerba Pharmaceuticals Inc. ($ZYNE) Stock | Shares Skyrocket On ... | zyne stock priceAs of the end of the division Chartwell Advance Partners, LLC had acquired a absolute of 14,978 shares growing its backing by 19.9%. The amount of the advance in ZYNE added from $1,516,000 to $1,534,000 accretion 1.2% for the advertisement period. As of division end Granite Point Capital Management, L.p. had bought 36,200 shares growing its pale by 36.6%. The amount of the advance in (ZYNE) went from $1,990,000 to $2,294,000 a change of 15.3% back the aftermost quarter.
On August 8 the banal appraisement was downgraded to “Neutral” from “Buy” and a amount ambition of $7.00 was set in a account from H.C. Wainwright. Equity analyst H.C. Wainwright bargain the amount ambition and downgraded the banal on August 8 alteration the amount cold from $22.00 to $7.00 and altering the appraisement from “Buy” to “Neutral”.
Advertisement
["1091.25"]
Maxim Bullish on Zynerba Pharmaceuticals Inc (ZYNE) Following ... | zyne stock priceOn August 15 the aggregation was rated “Market Perform” in a address from Oppenheimer bottomward from the antecedent “Outperform” rating. On August 15, 2017 the banal appraisement was afflicted to “Market Perform” according to a Jefferies address a cut from the antecedent “Buy” rating.
August 21 advance analysts at Canaccord Genuity maintained a aggregation appraisement of “Buy” and bargain the amount ambition to $9.00 from $35.00.
The aggregation is now bottomward from yesterday’s abutting of 10.37. The banal aftermost traded at $10.05 which is absolutely a bit college than the 50 day affective boilerplate of $7.68 and which is impressively college than the 200 day affective boilerplate of $7.68. The 50 day affective boilerplate was up by 30.84% and the 200 day boilerplate went up by 30.84%.
["582"]
Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) stock price target ... | zyne stock priceIn the aftermost balance address the EPS was $-2.60 and is accepted to be $-2.42 for the accepted year with 13,257,000 shares currently outstanding. Abutting quarter’s EPS is forecasted to be $-0.58 with abutting year’s EPS projected to be $-2.39.
Zynerba Pharmaceuticals, Inc., launched on January 31, 2007, is a specialty biologic company. The Aggregation is complex in developing and commercializing transdermal constructed cannabinoid treatments for patients with aerial unmet needs. Its development activity includes two artefact candidates: ZYN002 and ZYN001..
["582"]
Zynerba Pharma (NASDAQ:ZYNE) stock price target increased to ... | zyne stock price["388"]
["1425.9"]
Zynerba: Why I'm Not Buying The High - Zynerba Pharmaceuticals ... | zyne stock price["388"]
Breaking: Zynerba Pharmaceuticals (ZYNE) “Buy” Rating Reaffirmed ... | zyne stock price["597.52"]
ZYNE - Zynerba Pharmaceuticals Inc Stock quote - CNNMoney.com | zyne stock price["388"]
EU: Zynerba Pharmaceuticals (ZYNE) Stock Has Just Had Its “Buy ... | zyne stock price["194"]
Zynerba Pharmaceuticals (ZYNE) Files $57.5M Common Stock IPO | zyne stock price